While the FDA Form 483 is not as serious as a warning letter , it does shed light on hurdles the secretive company is facing as it attempts to reinvent the blood testing industry that has long been dominated by companies such as LabCorp and Quest Diagnostics . Holmes , who dislikes needles , ? has repeatedly stated that she dropped out of Stanford University to start Theranos out of a mission to make blood testing both easier and cheaper so as to encourage consumers to more closely monitor their own health without the need for a doctor ' s prescription .
